The mechanisms underlying the occurrence of thromboembolism in COVID-19 patients are largely unknown but they involve release of cytokines such as IL-6, IL-7 and TNF, endothelial injury, activation of monocytes and macrophages, complement-mediated microangiopathy, dysregulation of renin-angiotensin system and NETs. The gene discussed is IL6; the disease is COVID-19.